PCN152 Patient-Relevant Endpoints (PRE) in Oncology - Current Issues in the Context of Early Benefit Assessment (EBA) in Germany- An Industry Perspective
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.2192
https://www.valueinhealthjournal.com/article/S1098-3015(12)03906-X/fulltext
Section Title :
Cancer
Section Order :
844
First Page :
A437
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03906-X&doi=10.1016/j.jval.2012.08.2192